WHY US
As its core goal, the Ph.D. Program for Cancer Molecular Biology and Drug Discovery strives to develop new treatments for cancer. Our mission is to help students cultivate the critical thinking and empirical research skills needed to understand cancer biology and develop novel cancer drugs. We provide an interdisciplinary curriculum, close interaction with research specialists, and the opportunity to develop relationships through on-site visits to industry centers. At the Ph.D. Program for Cancer Molecular Biology and Drug Discovery, top students from around the world learn to apply basic research to clinical translational medicine – and make breakthrough discoveries possible.
COURSES INTRODUCTION
The Ph.D. Program for Cancer Molecular Biology and Drug Discovery is designed to nurture world-class professionals in cancer biology research and drug research. Courses under four main categories (Cancer Biology Research Basic, New Drug R&D, Cancer Research Experimental Design, and Biomedical Informatics) lay the foundation for independent thinking and judgment, innovative thinking and problem solving, and the technical aspects of conducting research. In addition to arranging on-site visits to biotech and pharmaceutical industries, the Program works closely with Taiwan Academia Sinica and TMU’s affiliated hospitals to provide students direct access to clinical and research resources.
CURRICULA
These 8 courses are required:
| ◆ Research ethics | 0 credit |
| ◆ Special topics in processing & translational research of medical science & technology | 2 credits |
| ◆ Seminar | 4 credits |
| ◆ Cell biology & artificial intelligence in biomedical informatics | 2 credits |
| ◆ Molecular cancer biology | 2 credits |
| ◆ Molecules medicine & drug discovery | 2 credits |
| ◆ Drug design & development | 2 credits |
| ◆ Dissertation | 12 credits |
Suggested Electives:
| ◆ Precision genomics & proteomics in medical application | 2 credits |
| ◆ Machine learning | 2 credits |
| ◆ Experimental design & research methods | 2 credits |
| ◆ Animal models of disease research | 2 credits |
| ◆ Epigenetics | 2 credits |
| ◆ Medical decision support | 2 credits |
| ◆ Bioinformatics in precision medicine | 2 credits |
| ◆ Stem cell translational research & therapeutics | 2 credits |
| ◆ Applied biostatistics | 2 credits |
Click here for a sample schedule, by semester
Semester 1
Required courses:
| ◆ Research ethics | 0 credit |
| ◆ Seminar | 1 credit |
| ◆ Molecular cancer biology | 2 credits |
| ◆ Molecules medicine & drug discovery | 2 credits |
Elective courses:
| ◆ Experimental design & research methods | 2 credits |
| ◆ Animal models of disease research | 2 credits |
| ◆ Epigenetics | 2 credits |
| ◆ Medical decision support | 2 credits |
| ◆ Bioinformatics in precision medicine | 2 credits |
| ◆ Stem cell translational research & therapeutics | 2 credits |
Semester 2
Required courses:
| ◆ Seminar | 1 credit |
| ◆ Cell biology & artificial intelligence in biomedical informatics | 2 credits |
| ◆ Drug design & development | 2 credits |
Elective courses:
| ◆ Applied biostatistics | 2 credits |
Semester 3
Required course:
| ◆ Seminar | 1 credit |
| ◆ Special topics in processing & translational research of medical science & technology | 2 credits |
Semester 4
Required courses:
| ◆ Seminar | 1 credit |
GRADUATION REQUIREMENTS
- A minimum of 30 credits, including 14 credits of required courses. Most of the course requirements can be completed in 2 years, candidates shall satisfy the requirements list below for the Ph.D. degree.
- English proficiency:
TOEFL ITP or TOEFL PBT:550
TOEFL CBT:213
TOEFL IBT:79
TOEIC:600
IELTS:5.5
First Certificate in English:FCE
GEPT:High-Intermediate - Thesis defense
FUTURE CAREER PATH
Armed with cutting-edge therapeutic strategies for cancer prevention and treatment, graduates of our program continue the fight to make cancer treatment breakthroughs. Whether by engaging in teaching or extended academic research or by developing cancer treatments or synthesizing new drug in clinical settings, our efforts are focused on translating basic research to cancer treatments, and helping cancer patients live longer and better lives.
Whereas, the student graduates from the Ph.D. Program for Cancer Molecular Biology and Drug Discovery was well trained for research scientist, editor (scientific and technical publications), physical therapist, physician, cancer registrar, and pharmacologists…etc.
